Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Extension for 43USSA1812 (A Randomized, Evaluator-blinded, No-treatment Controlled, Multi-center Study to Evaluate the Effectiveness and Safety of Sculptra Aesthetic for Correction of Cheek Wrinkles)

NCT04595331 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT04595331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04595331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Extension for 43USSA1812 (A Randomized, Evaluator-blinded, No-treatment Controlled, Multi-center Study to Evaluate the Effectiveness and Safety of Sculptra Aesthetic for Correction of Cheek Wrinkles)
Lead sponsor
Galderma R&D
Phase
Not applicable
Overall status
Completed
Start date
November 12, 2019
Completion date
July 20, 2022
Enrollment
111 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cheek, wrinkle